Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures

Kim, C. Kwon, Lee, Yin Rui, Ong, Lynnett, Gold, Michael, Kalali, Amir, Sarkar, Joydeep·2022·Journal of Alzheimer s Disease

DOI 10.3233/jad-215699

Cited by (243)

Items 101–200 of 243

The Role of Mitochondrial Dysfunction in Alzheimer’s: Molecular Defects and Mitophagy-Enhancing Approaches
Reem M. Farsi · 2023 · Life
An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research
Xiangzhong Zheng · 2024 · Cells
Fate or fault? Nurses’ perspectives on dementia prevention in German care facilities
Niklas Petersen · 2024 · SSM - Qualitative Research in Health
miRNA375-3p/rapamycin mediates the mTOR pathway by decreasing PS1, enhances microglial cell activity to regulate autophagy in Alzheimer's disease
Wang, Yuxiang, Xiao, Zixuan, Yin, Hanlan, Ren, Zhichao, Ma, Xueting, Wang, Yibo, Zhang, Yan, Fu, Xueqi, Zhang, Fuqiang, Zeng, Linlin · 2024 · Heliyon
Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer’s disease
Angelika Caputo, Amy Racine, Inès Paule, Pierre N. Tariot, Jessica B. S. Langbaum, Neva Coello, Marie‐Emmanuelle Riviere, J. Michael Ryan, Cristina López López, Ana Graf et al. · 2023 · Alzheimer s Research & Therapy
Binding interaction of acetylcholinesterase with steroidal pregnanes: insight from machine learning and atomistic simulation
Oludare Michael Ogunyemi, Oladimeji S. Macaulay, Gideon Ampoma Gyebi, Modupe M. Ogunyemi, Mary Olaoluwa Agunloye, Charles O. Olaiya · 2025 · Journal of Biomolecular Structure and Dynamics
Application of computational methods in the drug discovery and development of Alzheimer's disease
Qianqian Zhang, Xiaoqing Gong, Huanxiang Liu, Xiaojun Yao · 2025 · Acta Pharmaceutica Sinica B
Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease
Robert W.B. Love · 2024 · Journal of Alzheimer s Disease
An ALS assembly modulator signature in peripheral blood mononuclear cells: implications for ALS pathophysiology, therapeutics, and diagnostics
Shao Feng Yu, Maya Michon, Anuradha F. Lingappa, Kumar Paulvannan, Dennis Solas, Kim A. Staats, Justin K. Ichida, Debendranath Dey, Jeffrey Rosenfeld, Vishwanath R. Lingappa · 2025 · Clinical Proteomics
The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
Alyaa Mostafa, Stephanie Tiu, Farooq Ahmed Khan, Nusrath A Baig · 2025 · Annals of Indian Academy of Neurology
Combinatorial therapy in Alzheimer's disease
Mahendra Ashok Giri, Prakash N. Kendre, R. D. Bhalke, Vishal Vijay Pande, Kalyani Appasaheb Autade, Rajashri Balasaheb Sumbe · 2024 · Elsevier eBooks
Unveiling Gene Interactions in Alzheimer’s Disease by Integrating Genetic and Epigenetic Data with a Network-Based Approach
Keith L. Sanders, Astrid Marilyn Manuel, Andi Liu, Boyan Leng, Xiangning Chen, Zhongming Zhao · 2024 · Epigenomes
Decoding Alzheimer’s disease: acetylcholine and dopamine pathway disruptions as early markers of cognitive decline
Claudio Zaccone, Annalisa Nobili, Marcello D’Amelio · 2024 · Brain Communications
Synthetic control methods for n‐of‐1 and parallel‐group trials in Alzheimer's disease: A proof‐of‐concept study using the I‐CONECT
Chao‐Yi Wu, Liu Chen, John R. Dickson, Bo Zhang, Steven Edward Arnold, Hiroko Hayama Dodge · 2025 · Alzheimer s & Dementia
Monocyte inflammation and resilience to Alzheimer’s disease: novel genetic risk genes identified by transcriptome-wide association study
Yousef Mustafa, Leighanne R. Main, Makaela Mews, Vaibhav A. Janve, Timothy J. Hohman, Jonathan L. Haines, Yeunjoo E. Song, Anthony J. Griswold, Margaret Ann Pericak‐Vance, William K. Scott et al. · 2025 · Translational Psychiatry
Combined Preventive and Preconditioning Treatments for the Comorbidity of Alzheimer’s Disease and Ischemic Stroke in a GluN3A Knockout Mouse and a 5xFAD Mouse
Shan Ping Yu, Xiaohuan Gu, Michael Qize Jiang, Ananth Sastry, Lingyue Wu, Yiying Li, Ling Wei · 2025 · Cells
A Blood‐Brain Barrier‐Penetrant Ag(III) Corrole Compound Rescues Alzheimer's Disease Pathology by Targeting Aβ42‐Induced Oxidative Stress
Arup Tarai, Tuhina Mitra, Tanmoy Pain, Jyotiprakash Mallick, Rwiddhi Chakraborty, Kallam Tejaswi, Swagata Ghatak, Sanjib Kar · 2026 · Advanced Science
RETRACTED: Challenges in Alzheimer’s Drug Development: Failures, Therapeutic Barriers and Clinical Translation
Pratik Vediya, Aditi Soni, Ravi Ajudia, Bhavik R. Jani, K. Parekh, Udit Trivedi · 2026 · EPJ Web of Conferences · Retracted
Status of Alzheimer’s and Parkinson’s Disease Detections and Treatments
Phuong Hoang Nguyen, Philippe Derreumaux · 2026 · ACS Chemical Neuroscience
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells
Nicole R. West, Mattias F. Lindberg, Julien Dairou, Shawn MacGregor, Sahith Puthireddy, Laurent Meijer, Anita Bhattacharyya · 2026 · Disease Models & Mechanisms
Bibliometric analysis of global research on the role of apolipoprotein E in Alzheimer's disease
Zhanzhang Wang, Xiuqing Zhu, Yuguan Wen, Dewei Shang · 2023 · Heliyon
Utilization of fluorinated α-amino acids in small molecule drug design
Paul Richardson · 2025 · Expert Opinion on Drug Discovery
Using the urea cycle to shift astrocytes from harmful to helpful in Alzheimer's disease.
Ariel K. Frame, R. C. Cumming · 2022 · Cell Metabolism
Role of calcineurin and ionotropic glutamate receptors in Alzheimer's disease: A systematic review
Awgichew Behaile Teklemariam, Edgeit Abebe Zewde, Melaku Mekonnen Agidew, Sisay Ayalkibet Siyamrew, Lemlemu Maru, Zelalem Tilahun Muche · 2025 · Brain Disorders
miRNA and piRNA differential expression profiles in Alzheimer's disease: A potential source of pathology and tool for diagnosis
Benjamin Landon, Kumudu Subasinghe, Nathalie Sumien, Nicole Phillips · 2025 · Experimental Gerontology
Astrocytic Ornithine Decarboxylase 1 in Alzheimer’s Disease
Mridula Bhalla, Changjoon Justin Lee · 2025 · Experimental Neurobiology
Deep learning-based patient stratification for prognostic enrichment of clinical dementia trials
Colin J. Birkenbihl, Johann de Jong, Ilya Yalchyk, Holger Fröhlich, the Alzheimer’s Disease Neuroimaging Initiative · 2023 · medRxiv
Data-driven discovery of cell-type-directed network-correcting combination therapy for Alzheimer’s disease
Yaqiao Li, Carlota Pereda Serras, Jessica R. Blumenfeld, Min Xie, Yanxia Hao, Elise Deng, You Young Chun, Julia Holtzman, Alice An, Seo Yeon Yoon et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Biomarkers in CNS Drug Discovery, Drug Development, and Clinical Implementation
Valentina Di Caro, Claire Williams, Hilary A. North, Mary E. Hamby · 2025 · Wiley eBooks
Measuring the replicability of our own research
Richard E. Brown · 2024 · Journal of Neuroscience Methods
Digital seed amplification assay for TDP‐43 aggregate quantification in CSF
Ella Borberg, Zoe Swank, Tal Gilboa, Lily A. Wickland Shearer, Arek V. Melkonian, Justin C. Rolando, David R. Walt, Andrew M. Stern · 2026 · Alzheimer s & Dementia
Active immunization: A novel therapeutic strategy for treating Alzheimer's disease
Farhan Mazahir · 2025 · European Journal of Pharmacology
Cognitive co-ageing with inequitable political ecologies: Deconditioning & urban public transport
James Rupert Fletcher · 2025 · Social Science & Medicine
Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera
Yasmin Elbermawy, Sara El-Desouky, Reem K. Arafa, Sara Elfarrash, Ahmad Raafat Bassiouny · 2025 · Molecular Neurobiology
Protection of multiple aspects of Alzheimer’s disease pathology using dietary supplementation with taurine
Christina M. Tognoni, Rajshree Ghosh Biswas, Zeynep Melis Suar, Isabel Carreras, Alpaslan Dedeoglu, Bruce G. Jenkins · 2026 · Scientific Reports
Endocytic scaffolds at the crossroads of Alzheimer’s disease and neuronal aging
Jasmeet Kaur Shergill, Domenico Azarnia Tehran · 2026 · Biological Chemistry
Resource-stratified machine learning framework for cognitive status classification and mild cognitive impairment to dementia progression prediction
Jingmei Yang, Huitong Ding, Samad Amini, Boran Hao, Cody Karjadi, Rhoda Au, Ioannis Ch. Paschalidis · 2026 · Alzheimer s Research & Therapy
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Eleanor Drummond, Eryn L. Werry, Tomas Kavanagh, Sian Genoud, A Cho, Shihui Chen, Jonathan Du, David E. Hibbs, Michael Kassiou · 2026 · Molecular Neurodegeneration Advances
3-Hydroxyanthranilic Acid Delays Paralysis in Caenorhabditis elegans Models of Amyloid-Beta and Polyglutamine Proteotoxicity
Bradford Hull, Kayla M. Miller, Caroline Corban, Grant Backer, Susan Sheehan, Ron Korstanje, George L. Sutphin · 2024 · Biomolecules
Structure‐Activity Relationship of Fluorinated Benzenesulfonamides as Inhibitors of Amyloid‐β Aggregation
Mantas Žvirblis, Andrius Sakalauskas, Saeid Hadi Alijanvand, Virginija Dudutienė, Mantas Žiaunys, Rūta Sniečkutė, Daniel E. Otzen, Vytautas Smirnovas, Daumantas Matulis · 2024 · Chemistry - A European Journal
Infection, Neuroinflammation and Interventions for Healthy Brain and Longevity
Tamàs Fülöp, Charles Ramassamy, Guy Lacombe, Eric H. Frost, Alan Arthur Cohen, Serafim Rodrigues, Mathieu Desroches, Katsuiku Hirokawa, Benoît Laurent, Jacek Maciej Witkowski · 2024 · Healthy ageing and longevity
Stretching the structural envelope of imatinib to reduce β-amyloid production by modulating both β- and γ-secretase cleavages of APP
William J. Netzer, Anjana Sinha, Mondana H. Ghias, Emily Chang, Katherina Gindinova, Emily Mui, Ji-Seon Seo, Subhash C. Sinha · 2024 · Frontiers in Chemistry
Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer’s Disease
Elliot J. Glotfelty, Tobias E. Karlsson, Luis B. Tovar‐y‐Romo, Lars Olson, Brandon K. Harvey, Nigel H. Greig · 2025 · Current Neuropharmacology
Two-dimensional materials can inhibit Aβ fibrillation in Alzheimer's disease
Anupam Ghosh, Titas Kumar Mukhopadhyay, Ayan Datta · 2025 · Physical Chemistry Chemical Physics
Maximizing the utility of brain organoid models and overcoming their perceived limitations
Tyler J. Wenzel, Darrell D. Mousseau · 2024 · Elsevier eBooks
AROMHA Brain Health Test: A Remote Olfactory Assessment as a Screen for Cognitive Impairment
Benoît Jobin, Colin Magdamo, Daniela Delphus, Andreas Runde, Sean Reineke, Alysa Alejandro Soto, Beyzanur Ergun, Alefiya Dhilla Albers, Mark W. Albers · 2024 · medRxiv
Speech-related parameters are sensitive measures of acetylcholinesterase inhibitor therapy in mild Alzheimer’s disease
Éva Hegedűs, Magdolna Pákáski, Gábor Gosztolya, Ildikó Hoffmann, Ildikó Kovács, János Kálmán · 2024 · PLoS ONE
Diffusion MRI Allows Capturing the Amyloid-β and τ Proteins Status in Alzheimer’s Disease Continuum
Giorgio Dolci, Federica Cruciani, Lorenza Brusini, Lorenzo Pini, Ilaria Boscolo Galazzo, Vince D. Calhoun, Gloria Menegaz · 2024 · IEEE International Symposium on Biomedical Imaging (ISBI)
Amplifying Efficiency and Accuracy in Dementia Drug Development
Ondřej Lerch, Stephen Z. Levine, S. Sivakumaran, Michael William Lutz, Ornit Chiba‐Falek, Norman Alan Mazer, Menghis Bairu, Ira Haraldsen, P.M. Rossini, Peter Jeffrey Snyder et al. · 2024 · The Journal of Prevention of Alzheimer s Disease
Unveiling Gaps and Demographic Influences in Alzheimer’s Therapy: A Data-Centric Study of FDA-Approved Late-Phase Clinical Trials
Vaishnavi Milind Kalokhe, Simran Simran, Aftab Ahmad, Fathima Musthafa, Vishal Sachin Gangawane, Rajeev Singh Raghuvanshi, Saurabh Srivastava · 2025 · Neurological Sciences
Identifying latent classes of longitudinal change in picture naming in a population-based sample
Deborah Finkel, Ying Liu, Margaret Gatz, Stefan Schneider, Raymond Hernandez, Bart Orriëns, Arie Kapteyn · 2025 · Aging Clinical and Experimental Research
α-Asarone Maintains Protein Homeostasis Through SKN-1-Mediated Proteasome and Autophagy Pathways to Mitigate Aβ-Associated Toxicity in Caenorhabditis elegans
Congmin Wei, Xinyan Chen, Menglu Sun, Jinjin Cao, De-Chun Liao, Cheng Zhou, Hongbing Wang · 2025 · Antioxidants
Solving the 'Goldilocks problem' in dementia clinical trials with multimodal AI
Andrew E. Welchman, Zoe Kourtzi · 2025 · The Journal of Prevention of Alzheimer s Disease
A microfluidic biomimetic system from the blood-brain barrier to activated microglia towards anti-Mesial Temporal Lobe Epilepsy drug screening
Yunhua Wang, Meng Du, Zhanfei Xie, Huicheng Chen, Liang Lu, Lan Jiang, Lin Wang, Guoxia Zheng · 2025 · Analytical and Bioanalytical Chemistry
Features of Mitochondrial Dynamics in Different Brain Parts of Patients with Alzheimer’s Disease
Vladimir S. Sukhorukov, Tatiana I. Baranich, Olga V. Velts, Д. Н. Воронков, Ekaterina V. Shcherbak, Dmitry S. Lazarev, Dmitry A. Kharlamov, A. P. Raksha · 2025 · International Journal of Molecular Sciences
Saving the "brain rainforest" in Alzheimer's disease: from single-node protection to ecosystem restoration
Ke Xia, João Bettencourt Relvas, Xiao Zheng, Haiping Hao · 2025 · Targetome
Applying a statistical model-based AI method to identify prognostic factors for long-term cognitive decline in Alzheimer’s disease: Evidence from pooled placebo data of four phase III trials
Ryoichi Hanazawa, Hiroyuki Sato, Keisuke Suzuki, Akihiro Hirakawa · 2026 · International Journal of Medical Informatics
Current progress in pathway-targeted therapeutics for Alzheimer’s disease: mechanistic insights and windows of opportunity
Habab Ali Ahmad, Mahnoor Zafar, Tooba Khan, Muhammad Imran Khan · 2026 · Molecular and Cellular Biochemistry
Serious doubts about amyloid-β (Aβ) biomarkers and anti-Aβ immunotherapy
Poul Flemming Høilund‐Carlsen, Abass Alavi, Tommaso Costa, Rachael L. Neve, Mona-Elisabeth R. Revheim, Jorge R. Barrio · 2026 · Journal of Alzheimer s Disease
The mitochondria-synapse axis in Alzheimer’s disease: Lost coordination in early stages
Priyanshu Sharma, Navneet Kaur, Nandini Vasal, Kusum Solanki, Aditya Sunkaria · 2026 · Ageing Research Reviews
Regional alterations of parvalbumin interneurons in human App knock-in mouse model of Alzheimer’s disease pathology
Mercedes M. Gonzalez, Benjamin Magondu, Matthew JM Rowan, Craig R. Forest · 2026 · Neurobiology of Aging
Human Microglial Molecular Alterations in Aging and Alzheimer’s Disease
Karol Ann T. Baldo, Elisa Gozlan, Emmanuel Onyinyechukwu Chidebe, Ifeoluwa Oluleke Awogbindin, Marina Ocaña Prieto, Leslie Michelle M. Dalmacio, Benneth Ben-Azu, Dan Frenkel, Marie‐Ève Tremblay · 2026 · Cells
MINERVA: a public XAI-powered platform advancing multi-target discovery in Alzheimer’s disease
Nicola Gambacorta, Daniela Trisciuzzi, Fabrizio Mastrolorito, Francesco Leonetti, Cosimo Altomare, Modesto de Candia, Marco Catto, Nicola Amoroso, Fulvio Ciriaco, Orazio Nicolotti · 2026 · Journal of Cheminformatics
Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer’s Disease
Peter J. Morin, Quanwu Zhang, Weiming Xia, Donald R. Miller, Henry W. Querfurth, Amir Abbas Tahami Monfared · 2023 · Neurology and Therapy
Landscape of Phase II Trials in Alzheimer’s Disease
Alina Lee, Di Shan, David Jonathan Castle, Tarek K. Rajji, Clement Ma · 2023 · Journal of Alzheimer s Disease
Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
Shunian Xiang, Patrick J. Lawrence, Bo Peng, Chien‐Wei Chiang, Dokyoon Kim, Li Shen, Xia Ning · 2023 · Pacific Symposium on Biocomputing (PSB)
Constituents of Uncaria lanosa f. philippinensis and their anti-amyloidogenic activity
Mario A. Tan, Hayato Ishikawa · 2023 · Natural Product Research
A Network Pharmacology Study and Experimental Validation to Identify the Potential Mechanism of Heparan Sulfate on Alzheimer’s Disease-Related Neuroinflammation
Dong-Uk Kim, Bitna Kweon, Jinyoung Oh, Yebin Lim, Gyeongran Noh, Jihyun Yu, Hyang-Rin Kang, Tackmin Kwon, Kwang youll Lee, Gi‐Sang Bae · 2025 · Biomedicines
Medicinal Cannabis for Alzheimer's Disease
Genevieve Z. Steiner, Madilyn Coles, Kayla M. Jaye, Najwa‐Joelle Metri, Ali S Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan B. Russo et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
Concerns about the Amyloid Cascade Hypothesis and Reappraisals
Christian Behl · 2023 · Springer eBooks
Evidence for glutamate excitotoxicity that occurs before the onset of striatal cell loss and motor symptoms in an ovine Huntington’s Disease model
Andrew Jiang, Linya You, Renée R. Handley, Victoria Hawkins, Suzanne J. Reid, Jessie C. Jacobsen, Stefano Patassini, Skye R. Rudiger, Clive J. McLaughlan, Jennifer M. Kelly et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Dynamic Clinical Success Rates for Drugs in the 21st Century
Ying Zhou, Yintao Zhang, Zhen Chen, Shijie Huang, Yinghong Li, Jianbo Fu, Hongning Zhang, Donghai Zhao, Xichen Lian, Yuan Zhou et al. · 2024 · medRxiv
Dynamic Clinical Success Rates for Drugs in the 21st Century
Feng Zhu, Ying Zhou, Yintao Zhang, Zhen Chen, Shijie Huang, Yinghong Li, Jianbo Fu, Hongning Zhang, Donghai Zhao, Xichen Lian et al. · 2024 · Research Square
Cytokine expression patterns predict suppression of vulnerable neural circuits in a mouse model of Alzheimer’s disease
Dennis Chun Yin Chan, ChaeMin Kim, Rachel Y. Kang, Madison K. Kuhn, Samuel Cramer, Hayreddin Ünsal, Lynne M. Beidler, Kevin L. Turner, Thomas Neuberger, Nanyin Zhang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Immunomodulation
Thomas Wısnıewskı, Fernando Goñi · 2023 · Springer eBooks
The Amyloid Cascade Hypothesis Has to Deliver, Finally
Christian Behl · 2023 · Springer eBooks
Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
Emilijus Žilinskas, Arūnas Vaitkevičius · 2024 · Neurologijos seminarai
Virtual and Augmented Reality Games in the Treatment of Neurodegenerative Diseases: Systematic and Bibliographic Review (Preprint)
Martin Eckert, Thomas Ostermann, Jan Peter Ehlers, Gregor Hohenberg · 2024
Hypocholinergic Stress and Neuronal Pruning in Alzheimer's Disease
Ryan Walsh · 2024 · Qeios
A Machine Learning Approach to Predict Cognitive Decline in Alzheimer’s Disease Clinical Trials
Bhargav Teja Nallapu, Kellen K. Petersen, Tianchen Qian, İdris Demirsoy, Elham Ghanbarian, Christos A. Davatzikos, Richard B. Lipton, Ali Ezzati, Alzheimer’s Disease Neuroimaging Initiative · 2024 · medRxiv
Different drugs used as therapeutic targets against AD till date
Manisha Nahar, Aamir Ghafoor Khan, Ravina Rai, Deepali Jat · 2024 · Elsevier eBooks
Alzheimer’s disease is treatable by increased cerebral blood flow (CBF) from omentum to compensate for a decreased CBF in aging
Harry Sawyer Goldsmith · 2024 · Surgical Neurology International
HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer’s disease
Jon Esandi, Pedro Renault, Maria Dolores Capilla-López, Rebeca Blanch, Ángel Edo, David Ramirez-Gómez, Assumpció Bosch, Beatriz Almolda, Carlos A. Saura, Jesús Giraldo et al. · 2025 · Biomedicine & Pharmacotherapy
Microvascular dysfunction in a murine model of Alzheimer’s disease using intravital microscopy
Danielle Sidsworth, Noah Tregobov, Colin Jamieson, Jennifer Reutens-Hernandez, Joshua Yoon, Geoffrey W. Payne, Stephanie Sellers · 2025 · Frontiers in Aging Neuroscience
Regional susceptibility of PV interneurons in an hAPP-KI mouse model of Alzheimer’s disease pathology
Mercedes M. Gonzalez, Benjamin Magondu, Matthew JM Rowan, Craig R. Forest · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Gene Therapy Against Age-Related Diseases
Riya Rameshwar Rai, Sagar Hindurao Barage, Rajshri Singh · 2025 · IGI Global eBooks
Biomarkers as Outcome Measures in Clinical Trials of Alzheimer Disease
Rawan M. Tarawneh · 2025 · Springer eBooks
Translational pharmacology and biomarkers applied to GPCR
Dennis Özcelik, Filippo Andreetta, Elizabeth Louise van der Kam · 2025 · Elsevier eBooks
Latent classes and progression of Mini-Mental State Examination scores in young-onset dementia: Data from the Swedish Dementia Register
Deborah Finkel, Fanny Kårelind, Steven Howard Zarit, Helle Wijk, Therése Bielsten, Linda Johansson · 2025 · Journal of Alzheimer s Disease
An Indicator Cell Assay-based Multivariate Blood Test for Early Detection of Alzheimer’s Disease
Yijun Sherry Qi, Leslie Rae Miller, Mark D. D'Ascenzo, Jason D. Berndt, G. Adam Whitney, Fergal J. Duffy, Samuel A. Danziger, Elaine R. Peskind, Ge Li, Colin Louis Masters et al. · 2025 · medRxiv
Brexpiprazole: Pioneering medication for managing agitation in Alzheimer's disease
Ayesha F. Shaukat, Rumaisa Riaz, Nawal Khaliq, Zubayer Shams, Aymar Akilimali · 2025 · Journal of Alzheimer s Disease Reports
Bay leaves: the neuroprotective dietary spice via inhibition of amyloid-like aggregation
Nazish Mustafa, Sana Irfan Khan, Laila Anwar, Mir Muhammad Uzairullah, Huma Aslam Bhatti, Syed Abid Ali, Ghulam Abbas · 2025 · Metabolic Brain Disease
СОВРЕМЕННЫЕ ТЕРАПЕВТИЧЕСКИЕ СТРАТЕГИИ ЛЕЧЕНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА (обзор литературы)
Т.А. Авдеенко, N. M. Guseinova, Ф.Я. Джафарзаде, Alsu Zagorulko · 2025 · Успехи геронтологии
Machine learning-based prediction of future dementia using routine clinical MRI brain scans and healthcare data
Parminder Singh Reel, Salim Al‐Wasity, Craig Edwards, Smarti Reel, Esma Mansouri-Benssassi, Szabolcs Suveges, Muthu Rama Krishnan Mookiah, Susan Krueger, Emanuele Trucco, Emily Jefferson et al. · 2025 · medRxiv
Use of rodent models in drug discovery for Alzheimer’s disease
James E. Barrett, Joanne R. Mathiasen, Paul McGonigle · 2025 · Elsevier eBooks
Cftr nominates a novel therapeutic target for Alzheimer's disease: Evidence from integrative omics and in vitro validation
Haoran Li, Jun-Zhuo Shi, Meng-Jie Zhang, Lu-Yao Yun, Yunfeng Zhou, Yang-Yang He, Xi Li, Guan-hua Du, Xiaobin Pang, Mengwei Wang et al. · 2025 · Neuropharmacology
Additional file 1 of The therapeutic landscape of tauopathies: challenges and prospects
Jeffrey L. Cummings, María Isabel González, Martyn C. Pritchard, Patrick C. May, Leticia Toledo‐Sherman, Glenn A. Harris · 2024 · Figshare
Additional file 1 of Prediction of conversion from mild cognitive impairment to Alzheimer’s disease and simultaneous feature selection and grouping using Medicaid claim data
Zhang, Qi, Ron Coury, Tang, Wenlong · 2024 · Figshare
Additional file 1 of Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer’s disease
Angelika Caputo, Amy Racine, Inès Paule, Pierre N. Tariot, Langbaum, Jessica B., Neva Coello, Riviere, Marie-Emmanuelle, J. Michael Ryan, Lopez, Cristina Lopez, Ana Graf · 2023 · Figshare
Additional file 2 of Prediction of conversion from mild cognitive impairment to Alzheimer’s disease and simultaneous feature selection and grouping using Medicaid claim data
Zhang, Qi, Ron Coury, Tang, Wenlong · 2024 · Figshare